Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,335.30 -19.12 -0.12%
S&P 500 1,666.29 -1.18 -0.07%
Nasdaq 3,496.43 -2.53 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,818.30 -6.20 -0.22%
FTSE 100 6,759.33 +3.70 0.05%
DAX 8,440.47 -15.36 -0.18%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,370.70 -122.36 -0.52%
S&P/ASX 200 5,180.06 -28.98 -0.56%
  • Exchange: OTC US
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Products

Oxis International Inc

+ Add to Watchlist

OXIS:US

0.0103 USD 0.00000.00%

As of 20:10:00 ET on 05/20/2013.

Company Profile for Oxis International Inc (OXIS)

OXIS International, Inc. develops technologies and products to research, diagnose, treat, and prevent diseases of oxidative stress. The Company holds the rights to therapeutic classes of compounds in the area of oxidative stress. OXIS also develops, manufactures, and markets products and technologies to diagnose and treat diseases caused by oxidative stress.

Contact Information

Oxis International Inc

468 N Camden Drive
2nd Floor
Beverly Hills, CA 90210
United States
Phone: 1-310-860-5184
Fax: 1-650-212-2569

Key Executives for Oxis International Inc (OXIS)

David SaloffChairman/CEO/Acting CFO/SecyKurt BenjaminInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil